Menu

Blog

Dec 26, 2024

New Hope for Metastatic Colorectal Cancer Patients: A Targeted Approach With a Drug Called Encorafenib Gets FDA Approval

Posted by in category: biotech/medical

A groundbreaking FDA approval has introduced a new treatment option specifically designed for colorectal cancer patients with the BRAF V600E mutation.

Leave a reply